Adenosquamous Carcinoma of the Lung: A Microdissection Study of KRAS and EGFR Mutational and Amplification Status in a Western Patient Population

Molecular testing of pulmonary adenocarcinomas for EGFR and KRAS mutations is becoming more common as tyrosine kinase inhibitor therapy is used for EGFR-mutated adenocarcinomas. Adenosquamous carcinomas represent a hybrid carcinoma, and there is no literature addressing the frequency of EGFR and KRA...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of clinical pathology 2011-05, Vol.135 (5), p.783-789
Hauptverfasser:	TOCHIGI, Naobumi, DACIC, Sanja, NIKIFOROVA, Marina, CIEPLY, Kathleen M, YOUSEM, Samuel A
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Carcinoma, Adenosquamous - epidemiology Carcinoma, Adenosquamous - genetics Carcinoma, Adenosquamous - pathology European Continental Ancestry Group Female Gene Amplification Humans Investigative techniques, diagnostic techniques (general aspects) Lung Neoplasms - epidemiology Lung Neoplasms - genetics Lung Neoplasms - pathology Male Medical sciences Microdissection Mutation Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins p21(ras) ras Proteins - genetics Receptor, Epidermal Growth Factor - genetics United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!